• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV 1.22% $13.77

CLINUVEL PHARMACEUTICALS LIMITED

Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The... Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. The Company is engaged in managing and expanding commercial distribution of its lead drug candidate, SCENESSE, in Europe, the United States, Israel, and Australia for the treatment of a rare, genetic metabolic disorder, erythropoietic protoporphyria (EPP). The Company’s pipeline includes PRENUMBRA, NEURACTHEL, CUV9900, and Parvysmelanotide (VLRX001). PRENUMBRA is a liquid (non-solid) injectable formulation of afamelanotide designed to provide a flexible dose of afamelanotide, a synthetic analogue of natural a-melanocyte stimulating hormone. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH), for neurological, endocrinological and degenerative disorders.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CUV 14:38 38 11K
14:38 Last post  edgck Comments Created with Sketch.  38  Views Created with Sketch.  11K 
CUV 18/03/24 6 1.4K
18/03/24 Last post  skram1182 Comments Created with Sketch.  6  Views Created with Sketch.  1.4K 
CUV
Clinuvel compared to Imugene
2
15/03/24 64 38K
TRENDING NEWS

BREAKING: RBA keeps interest rate on hold at 4.35% in line with expectations

NEWS
19 Mar 2024
15/03/24 Last post  skram1182 Comments Created with Sketch.  64  Views Created with Sketch.  38K 
CUV 14/03/24 6 1.8K
14/03/24 Last post  Popp123 Comments Created with Sketch.  6  Views Created with Sketch.  1.8K 
CUV
Patience
14/03/24 5 1.5K
14/03/24 Last post  Melon felon! Comments Created with Sketch.  5  Views Created with Sketch.  1.5K 
CUV
News: CUV Clinuvel Pharmaceuticals To Start 12-Mnth On-Market Share Buy-Back Program Of 1.5 Mln...
14/03/24 0 176
14/03/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  176 
CUV
Clinuvel, Lady Gaga and other multi-millionaires event links
14/03/24 13 2.9K
14/03/24 Last post  Eagle0 Comments Created with Sketch.  13  Views Created with Sketch.  2.9K 
CUV 13/03/24 12 4.1K
13/03/24 Last post  minutesoup Comments Created with Sketch.  12  Views Created with Sketch.  4.1K 

See All Discussions arrow Created with Sketch.

Timeline

Update - Notification of buy-back - CUV
18 Mar 14:45
 
Notification of buy-back - CUV
14 Mar 10:55
 
CLINUVEL initiates on market share buy-back program
14 Mar 10:51
 
New case of SCENESSE efficacy in vitiligo presented at AAD
11 Mar 08:55
 
SCENESSE Presented at American Academy of Dermatology
08 Mar 09:36
 
Ceasing to be a substantial holder
05 Mar 20:04
 
View More arrow Created with Sketch.
(20min delay)
Last
$13.77
Change
-0.170(1.22%)
Mkt cap ! $690.2M
Open High Low Value Volume
$14.02 $14.05 $13.62 $1.084M 78.77K

Buyers (Bids)

No. Vol. Price($)
2 602 $13.77
 

Sellers (Offers)

Price($) Vol. No.
$13.80 48 1
View Market Depth
Last trade - 16.10pm 19/03/2024 (20 minute delay) ?
Last
$13.86
  Change
-0.170 ( 0.75 %)
Open High Low Volume
$14.04 $14.04 $13.62 10927
Last updated 15.59pm 19/03/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.